Cross-Neutralization of Four Paramyxoviruses by a Human Monoclonal Antibody
This article, published in Nature, reports the results of a study describing a human monoclonal antibody that potentially cross-neutralizes human respiratory syncytial virus (RSV) along with three other viruses of different species. The results indicate that the monoclonal antibody might be useful for the prophylaxis and therapy of severe RSV infections and identifies the prefusion F protein as a target for an RSV vaccine. ABSTRACT ONLY. (Learn how users in developing countries can gain free access to journal articles.)
Author: Corti D, Bianchi S, Vanzetta F, et al.
» Visit web page (English)
(Located at www.nature.com)
Citation: Corti D, Bianchi S, Vanzetta F, et al. Cross-Neutralization of Four Paramyxoviruses by a Human Monoclonal Antibody. Nature. 2013;501(7467):439-443.
Resource types: Peer-reviewed journal
Diseases/vaccines: Respiratory syncytial virus (RSV)